All Commentary articles
View all stories of the same content type.
-
Commentary
Cell and gene therapy rare disease drug development in the US – general principles, challenges and a landscape of mutual regulatory concession
Cell and gene therapy rare disease drug development in the US – general principles, challenges and a landscape of mutual regulatory concession
-
Commentary
Developing a digital people strategy to harness the power of generative AI
Artificial intelligence is a science and applied technology that involves deductive processing and machine learning subsequently performing human-like tasks
-
Commentary
Part 4. UK routes to registration for medicinal cannabis
Final article in a four part series considering uses of medicinal cannabis
-
Commentary
Part 3. The medical applications of cannabis
Third in a four part series considering uses of medicinal cannabis
-
Commentary
Part 2. Regulatory background of medicinal cannabis in EU and UK
Second in a four part series considering uses of medicinal cannabis
-
Commentary
Part 1. An introduction
to medicinal cannabisThe first in a four part series considering uses of medicinal cannabis
-
Commentary
‘Science is more than
a body of knowledge’How the Regulatory Rapporteur’s online platform will provide its online journal experience